| ¿µ¹® | poliovirus | ÇÑ±Û | Æú¸®¿À¹ÙÀÌ·¯½º |
|---|---|---|---|
| ¼³¸í | ÇÇÄڷ糪¹ÙÀÌ·¯½º°ú, ¿£Å׷ιÙÀÌ·¯½º¼ÓÀÇ ¹ÙÀÌ·¯½ºÀ̸ç, ȸ»öô¼ö¿°(¼Ò¾Æ¸¶ºñ)ÀÇ º´¿øÃ¼ÀÌ´Ù. 1, 2, 3ÇüÀÇ Ç÷ûÇüÀ¸·Î ºÐ·ùÇÑ´Ù. 1ÇüÀÌ Àü¸¶ºñ¼º ȸ¹é¼ö¿°ÀÇ 85%¸¦ Â÷ÁöÇÑ´Ù. ¿ÜÇǸ¦ °®Áö ¾Ê´Â Á¤À̽ʸéü, Á÷°æ 25~30¥ìm ÀÌ´Ù. °æ±¸ÀûÀ¸·Î ħÀÔÇÑ ÈÄ ÀÎµÎ¿Í ÀÛÀºÃ¢ÀÚ¿¡ °¨¿°Çϸç, ÁÖ·Î ¸²ÇÁÁ¶Á÷(ƯÈ÷ Æíµµ¿Í Àå°üÀÇ ÁýÇÕ¸²ÇÁ¼ÒÆ÷)¿¡¼ Áõ½ÄÇÏ¿©, ¹ÙÀÌ·¯½ºÇ÷ÁõÀ» ÀÏÀ¸Å°¸ç Àü½ÅÀ¸·Î ÆÛÁø´Ù. °¨¿°ÀÚÀÇ ´ëºÎºÐÀº ºñ±³Àû °æÁõ(99%´Â ºÒÇö¼º °¨¿°)À¸·Î ³¡³ªÁö¸¸, µå¹°°Ô ¹ÙÀÌ·¯½º°¡ Ç÷·ù¸¦ ¸Åü·Î ³úÀÇ ¿îµ¿°ÑÁú°ú ô¼öÀÇ ¾Õ»Ô¼¼Æ÷¿¡ µµ´ÞÇÏ¸é ¸¶ºñÁõ»óÀÌ ³ªÅ¸³´Ù. ¸¶ºñ¸¦ ³ªÅ¸³»´Â Áõ·Ê·Î´Â ±ÙÀ°Åë, ±ÙÀ°°Á÷ µî Àü±¸Áõ»óÀÌ ³ª¿À°í Áï½Ã À̿ϼº ¸¶ºñ°¡ ³ªÅ¸³´Ù. |
||
| MOPV | monovalent oral poliovirus vaccine |
|---|---|
| PVR | peripheral vascular resistance; perspective volume rendering; poliovirus receptor; postvoiding resid... |
| PVS | percussion, vibration, suction; persistent vegetative state; persistent viral syndrome; Plummer-Vins... |
| IPV | Inactivated poliovirus vaccine |
|---|---|
| OPV | Oral Poliovirus Vaccine |
| PV | Poliovirus |
| PVR | Poliovirus receptor |
| PV1 | Poliovirus type 1 |
| poliovirus | <virology> A member of the enterovirus group of Picornaviridae that causes poliomyelitis. (18 Nov 1997) |
|---|---|
| poliovirus hominis | The picornavirus (genus Enterovirus) causing poliomyelitis in humans; the route of infection is the alimentary tract, but the virus may enter the bloodstream and nervous system, sometimes causing paralysis of the limbs and, rarely, encephalitis; many infections are inapparent; serologic types 1, 2, and 3 are recognised, type 1 being responsible for most paralytic poliomyelitis and most epidemics. Synonym: poliovirus hominis, poliovirus. (05 Mar 2000) |
| poliovirus vaccine | A suspension of formalin-inactivated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used in the united states only for immunization of immunologically deficient patients and for primary immunization of unimmunised adults at risk. (12 Dec 1998) |
| poliovirus vaccine, oral | A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (12 Dec 1998) |
| poliovirus vaccines | Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine. See: Salk vaccine. (05 Mar 2000) |
| polioviruses | Species of enterovirus causing acute infection in humans and leading to nervous system damage in a minority of cases. Humans are the only natural host, but infection can also occur in non-human primates and experimentally in rodents. (12 Dec 1998) |
| polioviruses, human 1-3 | Species of enterovirus which are the causal agents of poliomyelitis in humans. Three serotypes (strains) exist: brunhilde (type 1), lansing (type 2), and leon (type 3). Transmission is by the faecal-oral route, pharyngeal secretions, or mechanical vector (flies). Both inactivated and live attenuated vaccines have proven effective in combatting the infection. (12 Dec 1998) |
| inactivated poliovirus vaccine | Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine. See: Salk vaccine. (05 Mar 2000) |
|---|---|
| oral poliovirus vaccine | An aqueous suspension of live, attenuated strains of poliomyelitis virus (types 1, 2, and 3) given orally for active immunization against poliomyelitis. See: Sabin vaccine. Synonym: poliomyelitis vaccines. (05 Mar 2000) |
| live oral poliovirus vaccine | Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine. See: Salk vaccine. (05 Mar 2000) |
Synonyms : Poliovirus Type 1, Poliovirus Type 2, Poliovirus Type 3, Polioviruses, poliovirus 1, Human, poliovirus 2, Human, poliovirus 3, Human
Synonyms : Inactivated Poliovirus Vaccine, Vaccine, Inactivated Poliovirus, Vaccine, Salk
Synonyms : Oral Poliovirus Vaccine, Vaccine, Oral Poliovirus, Vaccine, Sabin
Synonyms : Vaccines, Poliovirus
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
Æú¸®¿À¿¡½ºÄÚ¹Ú½º1ml/v - »õâ
|
Çѱ¹¹é½Å |
Poliovirus Vaccine, Live, Oral | Àü¹®ÀǾàǰ | ºñ±Þ¿© |
| poliovirus vaccine |
vaccine prepared from poliovirus to provide immunity to poliomyelitis
Ãâó: wordnet.princeton.edu/perl/webwn
|
|---|---|
| poliovirus |
the virus causing poliomyelitis
Ãâó: wordnet.princeton.edu/perl/webwn
|
| poliovirus v. inactivated |
[USP] a suspension of formalin-inactivated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, administered intramuscularly or subcutaneously for immunization against poliomyelitis in infants, children, and adolescents, as well as adults at increased risk of exposure. Called also Salk v.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| poliovirus v. live oral |
[USP] a live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture and used for immunization against poliomyelitis; administered orally. OPV induces both humoral and intestinal immunity and is excreted in the feces for at least several weeks after immunization. Because it can cause vaccine-associated paralytic poliomyelitis in those vaccinated and also their contacts, it is used only under special circumstances or in countries in which wild-type poliovirus has not been eradicated. OPV should not be administered to immunocompromised individuals or their household contacts. Called also Sabin v.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| poliovirus vaccine, inactivated |
ABBR: IPV. A poliovirus vaccine recommended for the prevention of paralytic poliomyelitis. The vaccine, which contains inactivated types I, II, and III polioviruses, is suitable for parenteral administration to a
Ãâó:
|
| poliovirus | the virus causing poliomyelitis |
|---|---|
| poliovirus | vaccine prepared from poliovirus to provide immunity to poliomyelitis |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|